{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:24:25Z","timestamp":1759710265801,"version":"build-2065373602"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004911","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Piau\u00ed","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004911","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.mehy.2020.109886","type":"journal-article","created":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T11:18:12Z","timestamp":1590837492000},"page":"109886","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["What would S\u00e9rgio Ferreira say to your physician in this war against COVID-19: How about kallikrein\/kinin system?"],"prefix":"10.1016","volume":"143","author":[{"given":"Lucas A.D.","family":"Nicolau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro J.C.","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana L.","family":"Vale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2020.109886_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.mehy.2020.109886_b0010","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1152\/ajplegacy.1949.156.2.261","article-title":"Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin","volume":"156","author":"Silva","year":"1949","journal-title":"Am J Physiol-Legacy Content"},{"key":"10.1016\/j.mehy.2020.109886_b0015","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF02144709","article-title":"Potentiation of bradykinin and eledoisin by BPF (bradykinin potentiating factor) from Bothrops jararaca venom","volume":"21","author":"Ferreira","year":"1965","journal-title":"Experientia"},{"key":"10.1016\/j.mehy.2020.109886_b0020","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1476-5381.1967.tb02148.x","article-title":"The disappearance of bradykinin and eledoisin in the circulation and vascular beds of the cat","volume":"30","author":"Ferreira","year":"1967","journal-title":"Br J Pharmacol Chemotherapy"},{"key":"10.1016\/j.mehy.2020.109886_b0025","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1748-1716.1898.tb00272.x","article-title":"Niere und Kreislauf1","volume":"8","author":"Tigerstedt","year":"1898","journal-title":"Skandinavisches Archiv F\u00fcr Physiologie"},{"key":"10.1016\/j.mehy.2020.109886_b0030","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1084\/jem.103.3.295","article-title":"The preparation and function of the hypertensin-converting enzyme","volume":"103","author":"Skeggs","year":"1956","journal-title":"J Exp Med"},{"key":"10.1016\/j.mehy.2020.109886_b0035","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1084\/jem.104.2.193","article-title":"The amino acid sequence of hypertensin II","volume":"104","author":"Skeggs","year":"1956","journal-title":"J Exp Med"},{"key":"10.1016\/j.mehy.2020.109886_b0040","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/0006-2952(63)90094-7","article-title":"Inhibition in vivo of the enzymatic inactivation of bradykinin and kallidin","volume":"12","author":"Erd\u00f6s","year":"1963","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.mehy.2020.109886_b0045","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/222956a0","article-title":"Metabolism of the angiotensins in isolated perfused tissues","volume":"222","author":"Bakhle","year":"1969","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2020.109886_b0050","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1152\/ajpregu.00535.2002","article-title":"The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction","volume":"285","author":"Schmaier","year":"2003","journal-title":"Am J Physiol Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/j.mehy.2020.109886_b0055","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1021\/bi00815a005","article-title":"Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom","volume":"9","author":"Ferreira","year":"1970","journal-title":"Biochemistry"},{"key":"10.1016\/j.mehy.2020.109886_b0060","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/0006-2952(71)90284-X","article-title":"Bradykinin potentiating peptide PCA-Lys-Trp-Ala-Pro","volume":"20","author":"Stewart","year":"1971","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.mehy.2020.109886_b0065","doi-asserted-by":"crossref","first-page":"19035","DOI":"10.1073\/pnas.0811464106","article-title":"Profile of Sergio Ferreira","volume":"105","author":"Downey","year":"2008","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.mehy.2020.109886_b0070","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1084\/jem.104.2.183","article-title":"The amino acid composition of hypertensin ii and its biochemical relationship to hypertensin I","volume":"104","author":"Lentz","year":"1956","journal-title":"J Exp Med"},{"key":"10.1016\/j.mehy.2020.109886_b0075","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme","volume":"275","author":"Tipnis","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2020.109886_b0080","first-page":"87","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1\u20139","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.mehy.2020.109886_b0085","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2020.109886_b0090","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J. Pathol."},{"key":"10.1016\/j.mehy.2020.109886_b0095","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1073\/pnas.0711241105","article-title":"Modulation of TNF- -converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF- production and facilitates viral entry","volume":"105","author":"Haga","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.mehy.2020.109886_b0100","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1128\/JVI.02202-13","article-title":"TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein","volume":"88","author":"Heurich","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2020.109886_b0105","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.biochi.2010.03.011","article-title":"Kininogens: More than cysteine protease inhibitors and kinin precursors","volume":"92","author":"Lalmanach","year":"2010","journal-title":"Biochimie"},{"key":"10.1016\/j.mehy.2020.109886_b0110","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1021\/bi702107v","article-title":"Steady-state and pre-steady-state kinetic evaluation of severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLproCysteine protease: development of an ion-pair model for catalysis","volume":"47","author":"Solowiej","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.mehy.2020.109886_b0115","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0167-0115(99)00026-9","article-title":"Angiotensin and aldosterone","volume":"80","author":"Lumbers","year":"1999","journal-title":"Regul Pept"},{"key":"10.1016\/j.mehy.2020.109886_b0120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/emmm.201000080","article-title":"Angiotensin II revisited: new roles in inflammation, immunology and aging","volume":"2","author":"Benigni","year":"2010","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.mehy.2020.109886_b0125","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2020.109886_b0130","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.21656","article-title":"Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics","author":"Gurwitz","year":"2020","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.mehy.2020.109886_b0135","doi-asserted-by":"crossref","unstructured":"Marin GH. Facts and reflections on COVID-19 and anti-hypertensives drugs, Drug Discov Ther. 2020;26. doi: 10.5582\/ddt.2020.01017.","DOI":"10.5582\/ddt.2020.01017"},{"key":"10.1016\/j.mehy.2020.109886_b0140","doi-asserted-by":"crossref","unstructured":"Santos RAS, e Silva ACS, Maric C, Silva DMR, Machado RP, de Buhr I, et al. Angiotensin-(1\u20137) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci 2003;100:8258\u201363. doi: 10.1073\/pnas.1432869100.","DOI":"10.1073\/pnas.1432869100"},{"key":"10.1016\/j.mehy.2020.109886_b0145","article-title":"Angiotensin converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system","author":"Gheblawi","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.mehy.2020.109886_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2019.104350","article-title":"ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway","volume":"113","author":"Ye","year":"2020","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.mehy.2020.109886_b0155","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/01.HYP.30.2.217","article-title":"Angiotensin-(1\u20137) induces Bradykinin-mediated hypotensive responses in anesthetized rats","volume":"30","author":"Abbas","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.mehy.2020.109886_b0160","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2125.1995.tb04447.x","article-title":"Bronchospasm and cough as adverse reactions to the ACE inhibitors captopril, enalapril and lisinopril. A controlled retrospective cohort study","volume":"39","author":"Wood","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.mehy.2020.109886_b0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007296","article-title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species","volume":"14","author":"Niemeyer","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.mehy.2020.109886_b0170","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.molbiopara.2013.01.002","article-title":"Substrate specificity studies of the cysteine peptidases falcipain-2 and falcipain-3 from Plasmodium falciparum and demonstration of their kininogenase activity","volume":"187","author":"Cotrin","year":"2013","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.mehy.2020.109886_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.apsb.2020.02.008","article-title":"Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods","author":"Wu","year":"2020","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/j.mehy.2020.109886_b0180","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1476-5381.1993.tb13946.x","article-title":"Bradykinin initiates cytokine-mediated inflammatory hyperalgesia","volume":"110","author":"Ferreira","year":"1993","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2020.109886_b0185","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/sj.bjp.0702347","article-title":"Bradykinin B1 and B2 receptors, tumour necrosis factor\u03b1and inflammatory hyperalgesia","volume":"126","author":"Poole","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2020.109886_b0190","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0014-2999(97)00153-2","article-title":"Bradykinin-induced knee joint incapacitation involves bradykinin B2 receptor mediated hyperalgesia and bradykinin B1 receptor-mediated nociception","volume":"326","author":"Tonussi","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.mehy.2020.109886_b0195","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1172\/JCI119009","article-title":"Bradykinin stimulates NF-kappaB activation and interleukin 1beta gene expression in cultured human fibroblasts","volume":"98","author":"Pan","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2020.109886_b0200","unstructured":"Barnes PJ. Effect of bradykinin on airway function, Agents Actions Suppl. 1992 Pt3:432-8. Review. PubMed PMID: 1462877."},{"key":"10.1016\/j.mehy.2020.109886_b0205","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/299256a0","article-title":"Bradykinin receptor-mediated chloride secretion in intestinal function","volume":"299","author":"Manning","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2020.109886_b0210","doi-asserted-by":"crossref","first-page":"L17","DOI":"10.1152\/ajplung.00498.2016","article-title":"Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9 bradykinin\/BKB1R axis and facilitates LPS-induced neutrophil infiltration","volume":"314","author":"Sodhi","year":"2018","journal-title":"Am J Physiol-Lung Cell Mol Physiol"},{"key":"10.1016\/j.mehy.2020.109886_b0215","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.npep.2009.12.004","article-title":"Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors","volume":"44","author":"Kuhr","year":"2010","journal-title":"Neuropeptides"},{"key":"10.1016\/j.mehy.2020.109886_b0220","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1475-2875-11-156","article-title":"Intracellular proteolysis of kininogen by malaria parasites promotes release of active kinins","volume":"11","author":"Bagnaresi","year":"2012","journal-title":"Malar J"},{"key":"10.1016\/j.mehy.2020.109886_b0225","article-title":"Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants","author":"Ul Qamar","year":"2020","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.mehy.2020.109886_b0230","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1126\/science.145.3638.1310","article-title":"Waterfall Sequence for Intrinsic Blood Clotting","volume":"145","author":"Davie","year":"1964","journal-title":"Science"},{"key":"10.1016\/j.mehy.2020.109886_b0235","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0049-3848(83)90244-X","article-title":"A comparison of the abilities of plasma kallikrein, \u03b2-factor XIIa, factor XIa and urokinase to activate plasminogen","volume":"29","author":"Miles","year":"1983","journal-title":"Thromb Res"},{"key":"10.1016\/j.mehy.2020.109886_b0240","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1152\/physrev.00013.2020","article-title":"Elevated plasmin(ogen) as a common risk factor for COVID-19 susceptibility","volume":"100","author":"Ji","year":"2020","journal-title":"Physiol Rev"},{"key":"10.1016\/j.mehy.2020.109886_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104362","article-title":"Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past","volume":"127","author":"Giannis","year":"2020","journal-title":"J Clin Virol"},{"key":"10.1016\/j.mehy.2020.109886_b0250","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.mehy.2020.109886_b0255","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/2121533a0","article-title":"Effect of bradykinin on the human isolated small and large intestine","volume":"212","author":"Fishlock","year":"1966","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2020.109886_b0260","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1152\/ajpgi.1989.256.1.G1","article-title":"Kinins as mediators of intestinal secretion","volume":"256","author":"Gaginella","year":"1989","journal-title":"Am J Physiol Gastrointestinal Liver Physiol"},{"key":"10.1016\/j.mehy.2020.109886_b0265","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1124\/jpet.103.059188","article-title":"Action of bradykinin in the submucosal plexus of guinea pig small intestine","volume":"309","author":"Hu","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.mehy.2020.109886_b0270","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/bjp.2008.288","article-title":"Bradykinin regulates human colonic ion transport in vitro","volume":"155","author":"Baird","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2020.109886_b0275","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/infdis\/jiv426","article-title":"Kinin B1 receptor inhibition with BI113823 reduces inflammatory response, mitigates organ injury, and improves survival among rats with severe sepsis","volume":"213","author":"Murugesan","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mehy.2020.109886_b0280","doi-asserted-by":"crossref","unstructured":"Guo J, Huang Z, Lin L, Lv J. Coronavirus Disease 2019 (COVID\u201019) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin\u2010Converting Enzyme Inhibitors\/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Journal of the American Heart Association 2020;9. doi: 10.1161\/jaha.120.016219.","DOI":"10.1161\/JAHA.120.016219"},{"key":"10.1016\/j.mehy.2020.109886_b0285","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.2337\/db08-0329","article-title":"Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy","volume":"58","author":"Westermann","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2020.109886_b0290","doi-asserted-by":"crossref","unstructured":"Ackerman BH, Kasbekar N. Disturbances of taste and smell induced by drugs. Pharmacotherapy, 1997;482-96. Review. PubMed PMID: 9165552.","DOI":"10.1002\/j.1875-9114.1997.tb03058.x"},{"key":"10.1016\/j.mehy.2020.109886_b0295","doi-asserted-by":"crossref","first-page":"H1000","DOI":"10.1152\/ajpheart.1993.265.3.H1000","article-title":"Localization of central pressor action of bradykinin in medulla oblongata","volume":"265","author":"Fior","year":"1993","journal-title":"Am J Physiol-Heart and Circulatory Physiol"},{"key":"10.1016\/j.mehy.2020.109886_b0300","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m1470","article-title":"Clinical features of Covid-19","author":"Vetter","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.mehy.2020.109886_b0305","doi-asserted-by":"crossref","unstructured":"Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurology 2020. doi: 10.1001\/jamaneurol.2020.1127.","DOI":"10.1001\/jamaneurol.2020.1127"},{"key":"10.1016\/j.mehy.2020.109886_b0310","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"The Lancet"},{"key":"10.1016\/j.mehy.2020.109886_b0315","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1517\/13543770902994389","article-title":"Bradykinin receptor antagonists \u2013 a review of the patent literature 2005\u20132008","volume":"19","author":"Fincham","year":"2009","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.mehy.2020.109886_b0320","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1517\/13543776.2012.730521","article-title":"Bradykinin B1 receptor antagonists: a patent update 2009\u20132012","volume":"22","author":"Boz\u00f3","year":"2012","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.mehy.2020.109886_b0325","doi-asserted-by":"crossref","unstructured":"Sharma JN. Basic and Clinical Aspects of Bradykinin Receptor Antagonists. Recent Developments in the Regulation of Kinins, Springer International Publishing; 2014, p. 1\u201314. doi: 10.1007\/978-3-319-06683-7_1.","DOI":"10.1007\/978-3-319-06683-7_1"},{"key":"10.1016\/j.mehy.2020.109886_b0330","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/14728222.2018.1409724","article-title":"Kinin B1 receptors as a therapeutic target for inflammation","volume":"22","author":"Qadri","year":"2017","journal-title":"Expert Opinion on Therapeutic Targets"},{"key":"10.1016\/j.mehy.2020.109886_b0335","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1358\/dot.2010.46.8.1507205","article-title":"Ecallantide: a plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema","volume":"46","author":"Stolz","year":"2010","journal-title":"Drugs of Today"},{"key":"10.1016\/j.mehy.2020.109886_b0340","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1021\/bi992048z","article-title":"Kinetic analysis of the role of zinc in the interaction of domain 5 of high-molecular weight kininogen (HK) with heparin\u2020","volume":"39","author":"Lin","year":"2000","journal-title":"Biochemistry"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720311063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720311063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:23:07Z","timestamp":1759692187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720311063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":68,"alternative-id":["S0306987720311063"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109886","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What would S\u00e9rgio Ferreira say to your physician in this war against COVID-19: How about kallikrein\/kinin system?","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109886","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109886"}}